The stability of truncated epidermal growth factor receptor mRNA is higher than that of the full-length receptor mRNA in rat hepatoma cells

Endocr J. 1997 Jun;44(3):403-8. doi: 10.1507/endocrj.44.403.

Abstract

Truncated and full-length epidermal growth factor (EGF) receptors are produced in rat liver cells. The truncated EGF receptor mRNA is almost identical to the full-length EGF receptor mRNA except for the lack of a 3' region of the full-length receptor mRNA. To understand the stability of rat EGF receptor mRNAs, we analyzed the expression of EGF receptor mRNAs in the hepatoma cell line, AH66 and liver cells. Ten, 7 and 5 kb full-length and 2.7 kb truncated EGF receptor mRNAs were detected in both of them. The half-lives of the 10 and 2.7 kb EGF receptor mRNAs were determined in AH66 cells using a transcriptional inhibitor, 5,6-dichlororibofuranosylbenzimidazole. The half-lives of the 10 and 2.7 kb mRNAs were 1.2 and 11 h, respectively. These results indicated that the truncated mRNA is 4 times more stable than the full-length mRNA in rat cells. As for the stability, the role of a sequence of 3'-untranslated region of the EGF receptor mRNA was discussed.

MeSH terms

  • Animals
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Drug Stability
  • ErbB Receptors / genetics*
  • Gene Expression*
  • Half-Life
  • Humans
  • Liver / metabolism
  • Liver Neoplasms, Experimental / metabolism*
  • Male
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Wistar
  • Tumor Cells, Cultured

Substances

  • Nucleic Acid Synthesis Inhibitors
  • RNA, Messenger
  • Dichlororibofuranosylbenzimidazole
  • ErbB Receptors